KOCAA
Knights of Columbus Asset Advisors’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-41,741
| Closed | -$146K | – | 422 |
|
|
2024
Q2 | $146K | Hold |
41,741
| – | – | 0.01% | 349 |
|
|
2024
Q1 | $116K | Sell |
41,741
-41,741
| -50% | -$116K | 0.01% | 336 |
|
|
2023
Q4 | $142K | Buy |
83,482
+41,741
| +100% | +$71K | 0.01% | 332 |
|
|
2023
Q3 | $43K | Hold |
41,741
| – | – | ﹤0.01% | 362 |
|
|
2023
Q2 | $48.4K | Hold |
41,741
| – | – | ﹤0.01% | 362 |
|
|
2023
Q1 | $63K | Hold |
41,741
| – | – | 0.01% | 346 |
|
|
2022
Q4 | $104K | Hold |
41,741
| – | – | 0.01% | 315 |
|
|
2022
Q3 | $176K | Hold |
41,741
| – | – | 0.02% | 284 |
|
|
2022
Q2 | $116K | Sell |
41,741
-42,384
| -50% | -$118K | 0.01% | 295 |
|
|
2022
Q1 | $481K | Buy |
84,125
+969
| +1% | +$5.54K | 0.04% | 250 |
|
|
2021
Q4 | $759K | Buy |
83,156
+1,407
| +2% | +$12.8K | 0.06% | 234 |
|
|
2021
Q3 | $874K | Buy |
81,749
+500
| +0.6% | +$5.35K | 0.08% | 230 |
|
|
2021
Q2 | $1.26M | Buy |
81,249
+630
| +0.8% | +$9.78K | 0.12% | 222 |
|
|
2021
Q1 | $1.31M | Buy |
80,619
+22,662
| +39% | +$367K | 0.13% | 234 |
|
|
2020
Q4 | $1.23M | Sell |
57,957
-410
| -0.7% | -$8.68K | 0.13% | 240 |
|
|
2020
Q3 | $865K | Sell |
58,367
-8,316
| -12% | -$123K | 0.11% | 244 |
|
|
2020
Q2 | $981K | Sell |
66,683
-1,238
| -2% | -$18.2K | 0.12% | 251 |
|
|
2020
Q1 | $797K | Sell |
67,921
-6,759
| -9% | -$79.3K | 0.1% | 274 |
|
|
2019
Q4 | $1.76M | Buy |
+74,680
| New | +$1.76M | 0.15% | 235 |
|